BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19657603)

  • 1. [Prostatic carcinoma screening: sense ur nonsense?].
    Madersbacher S; Vutuc C
    Wien Klin Wochenschr; 2009; 121(13-14):428-30. PubMed ID: 19657603
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspective: Enforce the clinical guidelines.
    Roobol M
    Nature; 2015 Dec; 528(7582):S123. PubMed ID: 26672782
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.
    Tikkinen KAO; Dahm P; Lytvyn L; Heen AF; Vernooij RWM; Siemieniuk RAC; Wheeler R; Vaughan B; Fobuzi AC; Blanker MH; Junod N; Sommer J; Stirnemann J; Yoshimura M; Auer R; MacDonald H; Guyatt G; Vandvik PO; Agoritsas T
    BMJ; 2018 Sep; 362():k3581. PubMed ID: 30185545
    [No Abstract]   [Full Text] [Related]  

  • 4. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
    Ito K
    Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate cancer screening--the evidence, the recommendations, and the clinical implications.
    Chou R; LeFevre ML
    JAMA; 2011 Dec; 306(24):2721-2. PubMed ID: 22203543
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for prostate cancer.
    Ruffin MT
    J Fam Pract; 1999 Aug; 48(8):581-2. PubMed ID: 10496634
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate-specific antigen testing: good or bad?
    Albertsen PC
    Oncologist; 2015 Mar; 20(3):233-5. PubMed ID: 25673105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.
    Höltl W; Lunglmayr G
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):440-1. PubMed ID: 16091868
    [No Abstract]   [Full Text] [Related]  

  • 9. [In depth analysis of 2 studies of prostate cancer screening--what makes sense?].
    Recker F
    Praxis (Bern 1994); 2010 Feb; 99(3):183-5. PubMed ID: 20127638
    [No Abstract]   [Full Text] [Related]  

  • 10. The prostate cancer conundrum.
    Albertsen PC
    J Natl Cancer Inst; 2003 Jul; 95(13):930-1. PubMed ID: 12837821
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy vs effectiveness in prostate-specific antigen screening.
    Albertsen PC
    J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSA Screening for Prostate Cancer.
    Quaas J
    Am Fam Physician; 2015 May; 91(9):Online. PubMed ID: 25955746
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment on: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
    Terris MK
    Eur Urol; 2009 Feb; 55(2):392; discussion 393. PubMed ID: 18353530
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate-specific antigen: a new(ish) study.
    Harv Mens Health Watch; 2010 Nov; 15(4):6-8. PubMed ID: 21166115
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate specific antigen (PSA) testing as screening for prostate cancer: the current controversy.
    Boyle P
    Ann Oncol; 1998 Dec; 9(12):1263-4. PubMed ID: 9932152
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for prostate cancer remains controversial.
    Stark JR; Mucci L; Rothman KJ; Adami HO
    BMJ; 2009 Sep; 339():b3601. PubMed ID: 19778971
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for prostate cancer: time to put all the data on the table.
    Haines IE; Ablin RJ; Miklos GL
    BMJ; 2016 May; 353():i2574. PubMed ID: 27226459
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostate cancer: numbers may not tell the whole story.
    Reynolds T
    J Natl Cancer Inst; 2000 Dec; 92(23):1873-6. PubMed ID: 11106674
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for prostate cancer: updated experience from the Tyrol study.
    Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
    Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.